Research Topic · Peer-Reviewed

Levodopa

Levodopa (also known as L-DOPA) is a medication used in the treatment of Parkinson's disease. It converts into dopamine in the brain, a neurotransmitter which is deficient in Parkinson's disease. This helps to improve motor function and reduce the symptoms of the disorder. Levodopa is the most commonly used treatmen…

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 10× across the literature 🗓 Reviewed June 2026

Overview

Levodopa (also known as L-DOPA) is a medication used in the treatment of Parkinson's disease. It converts into dopamine in the brain, a neurotransmitter which is deficient in Parkinson's disease. This helps to improve motor function and reduce the symptoms of the disorder. Levodopa is the most commonly used treatment for Parkinson's disease and is essential for managing the condition.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 5 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Levodopa, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Amino Acids.

Journal editorial board
Nicolas Inguimbert · France

This page summarises published research for orientation; it is not medical or professional advice.